Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma

Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma

The most common subtype of renal cell carcinoma is clear cell renal cell carcinoma (ccRCC). While localized ccRCC can be cured with surgery, metastatic disease has a poor prognosis. Recently, immunotherapy has emerged as a promising approach for advanced ccRCC. This review provides a comprehensive o...

Full description

Bibliographic Details
Main Authors: Lingbin Meng, Katharine A. Collier, Peng Wang, Zihai Li, Paul Monk, Amir Mortazavi, Zhiwei Hu, Daniel Spakowicz, Linghua Zheng, Yuanquan Yang
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cells
Subjects:
clear cell renal cell carcinoma
immune checkpoint inhibitors
immunotherapeutic combinations
bispecific antibodies
CAR T cells
vaccines
Online Access:https://www.mdpi.com/2073-4409/13/1/34

Internet

https://www.mdpi.com/2073-4409/13/1/34

Similar Items